# Yunhong Green Cti LTD.: overview YHGJ · Nasdaq · CIK 1042187 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/yhgj.md) · [Financials](/companies/yhgj/financials.md) · [Filings](/companies/yhgj/filings.md) · [Insiders](/companies/yhgj/insiders.md) Latest reported revenue: [$3.9m](/filings/0001493152-26-036497.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001493152-26-036497). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [2,540](/filings/0001493152-25-022194.md) | [6,165 d](/filings/0001493152-26-012156.md) | [4,802](/filings/0001493152-26-022647.md) | [5,457](/filings/0001493152-26-036497.md) | [2,953](/filings/0001493152-25-022194.md) | [6,493 d](/filings/0001493152-26-012156.md) | [6,154](/filings/0001493152-26-022647.md) | [3,900](/filings/0001493152-26-036497.md) | | Gross margin | % | [(0.8%)](/filings/0001493152-25-022194.md) | [33.0% d](/filings/0001493152-26-012156.md) | [18.0%](/filings/0001493152-26-022647.md) | [17.9%](/filings/0001493152-26-036497.md) | [2.3%](/filings/0001493152-25-022194.md) | [25.9% d](/filings/0001493152-26-012156.md) | [16.5%](/filings/0001493152-26-022647.md) | [13.8%](/filings/0001493152-26-036497.md) | | Operating margin | % | [(39.0%)](/filings/0001493152-25-022194.md) | [14.6% d](/filings/0001493152-26-012156.md) | [(3.7%)](/filings/0001493152-26-022647.md) | [0.3%](/filings/0001493152-26-036497.md) | [(33.3%)](/filings/0001493152-25-022194.md) | [(14.0%) d](/filings/0001493152-26-012156.md) | [(1.6%)](/filings/0001493152-26-022647.md) | [(8.2%)](/filings/0001493152-26-036497.md) | | Net margin | % | [(47.0%)](/filings/0001493152-25-022194.md) | [11.1% d](/filings/0001493152-26-012156.md) | [(8.7%)](/filings/0001493152-26-036497.md) | [(3.4%)](/filings/0001493152-26-036497.md) | [(27.5%)](/filings/0001493152-25-022194.md) | [(17.2%) d](/filings/0001493152-26-012156.md) | [(5.5%)](/filings/0001493152-26-036497.md) | [(13.9%)](/filings/0001493152-26-036497.md) | | Diluted EPS | $ per share | [(0.47)](/filings/0001493152-25-022194.md) | not reported | [(0.18)](/filings/0001493152-26-022647.md) | [(0.09)](/filings/0001493152-26-036497.md) | [(0.31)](/filings/0001493152-25-022194.md) | not reported | [(0.15)](/filings/0001493152-26-022647.md) | [(0.22)](/filings/0001493152-26-036497.md) | | Free cash flow | $k | [726 d](/filings/0001493152-25-022194.md) | [(2,165) d](/filings/0001493152-26-012156.md) | [950](/filings/0001493152-26-022647.md) | [722 d](/filings/0001493152-26-036497.md) | [560 d](/filings/0001493152-25-022194.md) | not reported | [209](/filings/0001493152-26-022647.md) | [2,296 d](/filings/0001493152-26-036497.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2022 (2022-09-30) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | [18.0](/filings/0001493152-24-011910.md) | [17.8](/filings/0001641172-25-004622.md) | [18.0](/filings/0001493152-26-012156.md) | [19.7](/filings/0001493152-26-012156.md) | | Gross margin | % | not reported | [17.4%](/filings/0001493152-24-011910.md) | [18.3%](/filings/0001641172-25-004622.md) | [20.1%](/filings/0001493152-26-012156.md) | [18.2%](/filings/0001493152-26-012156.md) | | Operating margin | % | not reported | [(6.2%)](/filings/0001493152-24-011910.md) | [(2.2%)](/filings/0001641172-25-004622.md) | [(3.4%)](/filings/0001493152-26-012156.md) | [(10.4%)](/filings/0001493152-26-012156.md) | | Net margin | % | not reported | [(8.1%)](/filings/0001493152-24-011910.md) | [(1.3%)](/filings/0001641172-25-004622.md) | [(8.3%)](/filings/0001493152-26-012156.md) | [(12.8%)](/filings/0001493152-26-012156.md) | | Diluted EPS | $ per share | not reported | [(0.22)](/filings/0001493152-24-011910.md) | [(0.01)](/filings/0001641172-25-004622.md) | [(0.07)](/filings/0001493152-26-012156.md) | [(1.01)](/filings/0001493152-26-012156.md) | | Free cash flow | $m | not reported | [2.2](/filings/0001493152-24-011910.md) | [(1.4)](/filings/0001641172-25-004622.md) | [(1.6)](/filings/0001493152-26-012156.md) | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/yhgj/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BANK OF MONTREAL /CAN/](/funds/927971.md) | 2026-06-30 | $47.8k | 15,875 | | New +15,875 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $26.2k | 8,707 | | Unchanged | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $11.9k | 3,963 | | Unchanged | | [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $7.2k | 2,397 | | Added +1,274 | | [ROYAL BANK OF CANADA](/funds/1000275.md) | 2026-06-30 | $2.0k | 619 | | Added +618 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $602 | 200 | | Added +92 | | [CITIGROUP INC](/funds/831001.md) | 2026-06-30 | $39 | 13 | | Added +12 | ## Recent filings [All 520 filings](/companies/yhgj/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-05 | 16:48 ET | [8-K](/filings/0001493152-26-045723.md) | 1.01 Entry into a material agreement; 5.08 Item not in the standard list; 9.01 Financial statements and exhibits | 0001493152-26-045723 | | 2026-08-07 | 14:37 ET | [10-Q](/filings/0001493152-26-036497.md) | Quarterly report, period 2026-06-30 | 0001493152-26-036497 | | 2026-05-13 | 15:19 ET | [10-Q](/filings/0001493152-26-022647.md) | Quarterly report, period 2026-03-31 | 0001493152-26-022647 | | 2026-04-27 | 19:55 ET | [8-K](/filings/0001493152-26-019118.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001493152-26-019118 | | 2026-03-31 | 16:46 ET | [8-K](/filings/0001493152-26-013955.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001493152-26-013955 | | 2026-03-23 | 20:05 ET | [10-K](/filings/0001493152-26-012156.md) | Annual report, period 2025-12-31 | 0001493152-26-012156 | | 2026-02-18 | 20:59 ET | [8-K](/filings/0001493152-26-007324.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-007324 | | 2026-01-23 | 20:55 ET | [8-K](/filings/0001493152-26-003370.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-003370 | | 2025-12-08 | 20:55 ET | [8-K](/filings/0001493152-25-026623.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-026623 | | 2025-12-01 | 20:55 ET | [8-K](/filings/0001493152-25-025549.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001493152-25-025549 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001493152-26-012156.md), filed Mar 23, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/564408a7-e12e-4958-a61b-65fe2fa78757) ## About the filer - CIK: 1042187 - Tickers: YHGJ - Exchange: Nasdaq - SIC code: 3060 Fabricated Rubber Products, NEC - State of incorporation: IL - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.